Cargando…
Improving clinical trial transparency at UK universities: Evaluating 3 years of policies and reporting performance on the European Clinical Trial Register
BACKGROUND: January 2019, the House of Commons’ Science and Technology Committee sent letters to UK universities admonishing them to achieve compliance with results reporting requirements for Clinical Trials of Investigative Medicinal Products by summer 2019. This study documents changes in the clin...
Autores principales: | Mirjam Keestra, Sarai, Rodgers, Florence, Gepp, Sophie, Grabitz, Peter, Bruckner, Till |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036155/ https://www.ncbi.nlm.nih.gov/pubmed/35168372 http://dx.doi.org/10.1177/17407745211071015 |
Ejemplares similares
-
Adoption of World Health Organization Best Practices in Clinical Trial Transparency Among European Medical Research Funder Policies
por: Bruckner, Till, et al.
Publicado: (2022) -
Clinical trial reporting performance of thirty UK universities on ClinicalTrials.gov—evaluation of a new tracking tool for the US clinical trial registry
por: Keestra, Sarai Mirjam, et al.
Publicado: (2021) -
Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs
por: Rodgers, Florence, et al.
Publicado: (2021) -
Making a COVID-19 vaccine that works for everyone: ensuring equity and inclusivity in clinical trials
por: Pepperrell, Toby, et al.
Publicado: (2021) -
Are European clinical trial funders policies on clinical trial registration and reporting improving? A cross-sectional study
por: O’Riordan, Marguerite, et al.
Publicado: (2023)